Skip to main content

Rheumatology

Featured Article
Patients with rheumatic diseases who are on tumor-necrosis-factor inhibitor therapy can safely receive the live varicella zoster vaccine, without risking vaccine-related infection, a new study…
Polypharmacy can predict clinical outcomes among persons with rheumatoid arthritis, according to results of a new study.

Insights

A. Mark Fendrick, MD, director at the University of Michigan Center for Value-Based Insurance Design, weighs the pros and cons of patient support programs, focusing on value-based insurance models and out of pocket costs.
Alice B. Gottlieb, MD, PhD, clinical professor of dermatology at the Icahn School of Medicine at Mount Sinai in New York, discusses the importance of early identification for patients with psoriatic arthritis as well as treatments that are currently…
Peter M ten Klooster, PhD, assistant professor at the University of Twente in Enschede in the Netherlands, discusses why achieving early remission for patients with rheumatoid arthritis is important to payers and how it can result in substantial…
Beau Norgeot, MS, of Bakar Computational Health Sciences Institute at the University of California, explains how artificial intelligence (AI) impacts the cost of care for patients with complex diseases, including rheumatoid arthritis, and highlights…
Back to Top